AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms
Systemic lupus erythematosus (SLE) is a complex autoimmune disorder that affects individuals globally, yet there is a significant lack of data regarding its prevalence and management, particularly in Asian populations like Pakistan. To address this gap, we are initiating a groundbreaking project to establish a Lupus Registry in Pakistan. Our aim is to gain a better understanding of how SLE presents and progresses within the Pakistani population. By collecting detailed information on we hope to provide valuable insights that can tailor diagnostic and therapeutic approaches to suit the local context. This project will enroll adult SLE patients initially from Fauji Foundation Hospital Rawalpindi, with plans to expand to other centers nationwide. Trained healthcare professionals will collect data through structured protocol as outlined in detailed project description. Through rigorous data
Sign in to get the eligibility rules as simple questions to take to your doctor.
AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy
HealthTeky